ArticleBreast cancer research and treatment2026

Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 study.

Matheus de Oliveira Andrade et al.PubMed ↗Publisher ↗

No numbers read from the abstract.